Illumina Inc. (ILMN)

276.05
6.60 2.30
NASDAQ : Health Technology
Prev Close 282.65
Open 282.35
Day Low/High 273.74 / 286.20
52 Wk Low/High 167.98 / 293.15
Volume 551.11K
Avg Volume 763.00K
Exchange NASDAQ
Shares Outstanding 147.00M
Market Cap 42.05B
EPS 5.00
P/E Ratio 74.30
Div & Yield N.A. (N.A)

Latest News

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

The crash of oil will only accelerate the move.

Kaskela Law LLC Announces Investigation Of Illumina, Inc. On Behalf Of Stockholders

Kaskela Law LLC Announces Investigation Of Illumina, Inc. On Behalf Of Stockholders

Kaskela Law LLC has commenced an investigation of Illumina, Inc. ("Illumina" or the "Company") (Nasdaq: ILMN) on behalf of the Company's stockholders.

Illumina Acquires Edico Genome To Accelerate Genomic Data Analysis

Illumina Acquires Edico Genome To Accelerate Genomic Data Analysis

Illumina, Inc. (NASDAQ: ILMN) today announced that it acquired Edico Genome, the leading provider of data analysis acceleration solutions for next-generation sequencing (NGS).

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invites investors to participate via webcast.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Breaches Of Fiduciary Duties By Management Of Illumina, Inc. - ILMN

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Breaches Of Fiduciary Duties By Management Of Illumina, Inc. - ILMN

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by management of Illumina, Inc.

Jim Cramer: Follow the Bouncing Equities

Jim Cramer: Follow the Bouncing Equities

Markets start day with a bungee jump.

Illumina Reports Financial Results For First Quarter Of Fiscal Year 2018

Illumina Reports Financial Results For First Quarter Of Fiscal Year 2018

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the first quarter of fiscal year 2018.

Square Is One of 4 Upset Picks in Our Latest 'Sweet 16' Stock Selections

Square Is One of 4 Upset Picks in Our Latest 'Sweet 16' Stock Selections

Watch for these upstart names to topple some big-caps going forward.

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invites investors to participate via webcast.

Illumina Reports Financial Results For Fourth Quarter And Fiscal Year 2017

Illumina Reports Financial Results For Fourth Quarter And Fiscal Year 2017

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2017.

Illumina Awarded $26.7M In Patent Suit Against Ariosa Diagnostics, Inc.

Illumina Awarded $26.7M In Patent Suit Against Ariosa Diagnostics, Inc.

Illumina, Inc. (NASDAQ: ILMN) announced today that a federal jury in San Francisco has ruled in its favor in a patent infringement suit filed against Ariosa Diagnostics, Inc.

Jim's Daily Rundown

In today's video, Jim discusses the government shutdown, an Eli Lilly downgrade, Schlumberger after Friday's earnings, and several other market-related topics.

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

It's hard to understand the magnitude of the change.

Jim's Daily Rundown

Jim discusses yesterday's market reversal and what to look for, GE news, Apple, healthcare and the financials.

Illumina To Announce Fourth Quarter And Fiscal Year 2017 Financial Results On Tuesday, January 30, 2018

Illumina To Announce Fourth Quarter And Fiscal Year 2017 Financial Results On Tuesday, January 30, 2018

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for fourth quarter and fiscal year 2017 following the close of market on Tuesday, January 30, 2018.

Luna DNA Announces Dawn Barry, Former Illumina VP, As President

Luna DNA Announces Dawn Barry, Former Illumina VP, As President

Barry joins existing leadership team, which includes several Illumina veterans, to drive discovery of genomic data, enabled by the blockchain

Jim's Daily Rundown

In today's video, Jim discusses our newest initiation in Constellation Brands, Danaher at the JP Morgan Healthcare conference, and energy stocks.

Cramer: Lessons From the Market and ICR

Cramer: Lessons From the Market and ICR

You can make a case to buy any of the stocks of the companies at ICR.

Thermo Fisher Scientific And Illumina Sign Agreement To Provide Research Market Broader Access To Ion AmpliSeq Technology

Thermo Fisher Scientific And Illumina Sign Agreement To Provide Research Market Broader Access To Ion AmpliSeq Technology

Thermo Fisher Scientific and Illumina, Inc. (NASDAQ: ILMN) today announced they have signed a commercial agreement that enables Illumina to sell Ion AmpliSeq technology to researchers who conduct scientific studies on...

The ISeq™ 100 Delivers The Data Quality And Accuracy That Illumina Is Known For, At A Price Point Of Less Than $20,000.(Photo: Business Wire)

The ISeq™ 100 Delivers The Data Quality And Accuracy That Illumina Is Known For, At A Price Point Of Less Than $20,000.(Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN) announced today the launch of the iSeq™ 100 Sequencing System.

Illumina And KingMed Diagnostics Partner To Develop Next-Generation Sequencing Technology For Chinese FDA Approval

Illumina And KingMed Diagnostics Partner To Develop Next-Generation Sequencing Technology For Chinese FDA Approval

Illumina, Inc. (NASDAQ: ILMN) and KingMed Diagnostics (SSE: 603882.

Illumina To Webcast Upcoming Investor Conference Presentations

Illumina To Webcast Upcoming Investor Conference Presentations

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be presenting at the following investor conference and invited investors to participate via webcast.

Aimee Hoyt (Photo: Business Wire)

Aimee Hoyt (Photo: Business Wire)

Illumina, Inc. (NASDAQ:ILMN) today announced Aimee Hoyt, an accomplished and strategic talent leader, will head its human resources team.

Six Off the Beaten Path Healthcare Stock Gems

Six Off the Beaten Path Healthcare Stock Gems

These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.

Illumina Opens First Commercial And Customer Training Center In France

Illumina Opens First Commercial And Customer Training Center In France

Illumina, Inc. (NASDAQ:ILMN) today announced the opening of its Solutions Center on the Genopole Campus in Évry, near Paris.

TheStreet Quant Rating: B (Buy)